Dissolution-and-reduction CVD synthesis of few-layer graphene on ultra-thin nickel film lifted off for mode-locking fiber lasers.

The in-situ dissolution-and-reduction CVD synthesized few-layer graphene on ultra-thin nickel catalyst film is demonstrated at temperature as low as 550 °C, which can be employed to form transmission-type or reflection-type saturable absorber (SA) for mode-locking the erbium-doped fiber lasers (EDFLs). With transmission-type graphene SA, the EDFL shortens its pulsewidth from 483 to 441 fs and broadens its spectral linewidth from 4.2 to 6.1 nm with enlarging the pumping current from 200 to 900 mA. In contrast, the reflection-type SA only compresses the pulsewidth from 875 to 796 fs with corresponding spectral linewidth broadened from 2.2 to 3.3 nm. The reflection-type graphene mode-locker increases twice of its equivalent layer number to cause more insertion loss than the transmission-type one. Nevertheless, the reflection-type based saturable absorber system can generate stabilized soliton-like pulse easier than that of transmission-type system, because the nonlinearity induced self-amplitude modulation depth is simultaneously enlarged when passing through the graphene twice under the retro-reflector design.

Dual-band wavelength tunable nonlinear polarization rotation mode-locked Erbium-doped fiber lasers induced by birefringence variation and gain curvature alteration.

With the combining effects of the fiber birefringence induced round-trip phase variation and the gain profile reshaping induced spectral filtering in the Erbium-doped fiber laser (EDFL) cavity, the mechanism corresponding to the central wavelength tunability of the EDFL passively mode-locked by nonlinear polarization rotation is explored. Bending the intracavity fiber induces the refractive index difference between orthogonal axes, which enables the dual-band central wavelength shift of 2.9 nm at 1570 nm region and up to 10.2 nm at 1600 nm region. The difference between the wavelength shifts at two bands is attributed to the gain dispersion decided by the gain spectral curvature of the EDFA, and the spacing between two switchable bands is provided by the birefringence induced variation on phase delay which causes transmittance variation. In addition, the central wavelength shift can also be controlled by varying the pumping geometry. At 1570 nm regime, an offset of up to 5.9 nm between the central wavelengths obtained under solely forward or backward pumping condition is observed, whereas the bidirectional pumping scheme effectively compensates the gain spectral reshaping effects to minimize the central wavelength shift. In contrast, the wavelength offset shrinks to only 1.1 nm when mode-locking at 1600 nm under single-sided pumping, as the gain profile strongly depends on the spatial distribution of the excited erbium ions under different pumping schemes. Except the birefringence variation and the gain spectral filtering phenomena, the gain-saturation mechanism induced refractive index change and its influence to the dual-band central wavelength tunability are also observed and analyzed.

Echinocandins in invasive candidiasis.

We summarise a recent meeting, sponsored by Pfizer Inc., where experts in Asia shared their clinical experience in managing IC. The echinocandins have demonstrated good activity against non-albicans infections and also azole-resistant strains, both preclinically and in recent clinical trials. As well as proving efficacious, echinocandins have a favourable safety profile and are well tolerated, including among inpatient subpopulations, such as transplant recipients and those with renal or hepatic dysfunction. In addition the echinocandins generally have minimal drug-drug interactions, unlike the oral azoles, which have multiple effects on cytochrome P450-mediated drug metabolism. Echinocandins are characterised by a good safety profile, few drug-drug interactions and good susceptibilities. With the increase in potentially azole-resistant non-albicans infections, echinocandins may become the first-line treatment of choice for many patients.

Molecular epidemiology and control of nosocomial methicillin-resistant Staphylococcus aureus infection in a teaching hospital.

BACKGROUND AND PURPOSE: Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection is difficult to control. Due to a dramatic increase in the nosocomial MRSA infection rate at our hospital from 2000 to 2001, this study was conducted to identify the source of these infections and the effectiveness of control measures. METHODS: 179 healthcare workers (HCWs) were screened for carriage of MRSA. Starting in April 2001, all patients with MRSA infection or colonization were put in strict contact and cohort isolation. The bacterial isolates of HCW carriers and patients with MRSA infection from April 2001 to September 2001 were subjected to antimicrobial susceptibility testing by disk-diffusion method and molecular typing by pulsed-field gel electrophoresis (PFGE). RESULTS: Fifteen HCWs were found to be carriers of MRSA. They were all given topical mupirocin treatment. After these interventions, the nosocomial MRSA infection rate decreased from 1.23 to 0.53 per 1000 patient-days. All 61 MRSA isolates available for antimicrobial susceptibility testing and molecular typing were multidrug resistant. PFGE study revealed 2 predominant types, type C and type Y, comprising 36 and 12 isolates, respectively. CONCLUSIONS: The current study demonstrates the importance of measures to control nosocomial MRSA infections in hospitals that already have a high incidence of endemic MRSA infection. Elimination of carriage by healthcare workers, and strict contact and cohort isolation are the main effective measures.